Asenapine versus placebo for schizophrenia

Author:

Hay Alistair1,Byers Amy1,Sereno Marco1,Basra Manpreet Kaur1,Dutta Snigdha1

Affiliation:

1. The University of Nottingham; Institute of Mental Health; Jubilee Campus Innovation Park, Triumph Road Nottingham UK NG7 2TU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference122 articles.

1. Exposure-response analysis in patients with schizophrenia to assess the effect of asenapine on QTc prolongation;Chapel;Journal of Clinical Pharmacology,2009

2. Effect of asenapine versus quetiapine and placebo on QTc interval in patients with schizophrenia;Preskorn;European Neuropsychopharmacology,2007

3. Preskorn SH Chapel S Panagides J Effects of asenapine versus placebo on QTc interval in patients with schizophrenia American Psychiatric Association, 161st Annual Meeting, May 3-8, 2008, Washington, DC 2008

4. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic;Citrome;The International Journal of Clinical Practice,2009

5. Efficacy and safety of asenapine in patients with acute exacerbation of schizophrenia;Kane;Schizophrenia Research,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3